Pulmonary EmbolusEmergency

Pulmonary · Ward Pathways · Free — no sign-in

Pleuritic pain, dyspnea, tachycardia, hypoxia

ABCDE

O₂, IV access, monitoring; empirical anticoagulation if high suspicion; if shocked → resuscitate + thrombolysis pathway.

Calculators:
  1. Low probability → D-dimer to exclude. Otherwise → CT angiogram (V/Q if contrast/renal issue)
  2. High suspicion + delay → start anticoagulation empirically (heparin = LMWH efficacy)
  3. Maintenance: DOAC (apixaban) or warfarin
  4. Massive PE + heart strain / hypotension → thrombolytics
Decision tree
Haemodynamically unstable (massive PE)?
Yes
Resuscitate + thrombolysis (or embolectomy if lysis contraindicated)
No
High clinical probability (Wells)?
Yes
Anticoagulate + CTPA
No
D-dimer → if positive, CTPA; anticoagulate if confirmed

Order set

  • Wells score
  • D-dimer (low pretest) / CTPA
  • ECG, troponin
  • ABG
  • Anticoagulate empirically if high suspicion

Escalate / ICU

  • Hypotension / RV strain (massive PE)
  • Needs thrombolysis / embolectomy
  • Refractory hypoxia

Criteria

AdmitConfirmed/high-suspicion PE
ICUMassive PE, RV strain, post-thrombolysis
VasopressorsObstructive shock (with thrombolysis/embolectomy)
DischargeStable, anticoagulated, PESI low-risk, follow-up
Clinical detail — differentials, red flags, pitfalls, disposition
Red flags
  • Hypotension/RV strain (massive)
  • Syncope
  • Refractory hypoxia
Differentials
  • ACS
  • Pneumonia
  • Pericarditis
  • Aortic dissection
Common mistakes
  • D-dimer in high pretest probability
  • Delaying anticoagulation
Disposition & follow-up

Anticoagulate; massive → thrombolysis; risk-stratify (PESI).

Discharge package
MedicationsAnticoagulation (duration per provocation)
Follow-upAnticoagulation review; thrombophilia only if indicated
Warning symptomsChest pain, breathlessness, leg swelling, bleeding
💊 Treatment detail — doses & preparation
ApixabanDOAC (anti-Xa)
Dose5 mg BD (2.5 mg BD if ≥2 of: age ≥80, weight ≤60 kg, Cr ≥133). PE/DVT: 10 mg BD ×7 d then 5 mg BD
Preparation2.5/5 mg tablets (crushable)
MonitorBleeding, renal function; no routine monitoring
RivaroxabanDOAC (anti-Xa)
DosePE/DVT: 15 mg BD ×21 d then 20 mg OD with food. AF: 20 mg OD (15 mg if CrCl 15–49)
Preparation10/15/20 mg tablets; take 15/20 mg with food
MonitorBleeding, renal function
EnoxaparinLMW heparin
DoseTreatment: 1 mg/kg SC q12h (or 1.5 mg/kg OD). Prophylaxis: 40 mg SC OD
PreparationPre-filled syringes 20–150 mg; inject SC abdomen, do not expel air bubble
MonitorAnti-Xa if renal failure/pregnancy; platelets (HIT); renal dosing
Alteplase (tPA)thrombolytic
DoseStroke: 0.9 mg/kg (max 90 mg) — 10% bolus, 90% over 1 h. Massive PE: 100 mg over 2 h (or 50 mg bolus in arrest)
PreparationReconstitute 50 mg vial with 50 mL sterile water (1 mg/mL); dedicate a line
MonitorBP <185/110 before stroke lysis; neuro exam q15 min ×2 h; no antiplatelets ×24 h
📖 ESC / ACCP VTEReviewed July 2026

← Tuberculosis  ·  Sarcoidosis →

More Pulmonary pathways

Part of Pulmonary in Ward Pathways — open the interactive version.

ICU Decoded — original critical-care and internal-medicine pathways by Dr Javed Akhtar, each cited to a current guideline. For education and quick reference; verify every dose against local protocols before prescribing.

Open the app · Ward Pathways — 113 free cases · ICU Decoded chapters · Aladin Chirag bedside tools

About · Medical disclaimer · Privacy · Contact